South Korea Lung Cancer Diagnostics Market to 2032
Overview
The South Korea Lung Cancer Diagnostics Market is expected to reach a 265.97 USD Billion by 2032 and is projected to grow at a CAGR of 23.65% from 2025 to 2032.
Revenue, 2024 (USD Billion)
77.53
Forecast, 2032 (USD Billion)
265.97
CAGR, 2024 - 2032
23.65%
Report Coverage
South Korea
South Korea Lung Cancer Diagnostics Market 2018-2032 USD Billion
South Korea Lung Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 77.53 USD Billion
- Projected Market Size (2032): 265.97 USD Billion
- CAGR (2025-2032): 23.65%
Key Findings of South Korea Lung Cancer Diagnostics Market
- The South Korea Lung Cancer Diagnostics Market was valued at 77.53 USD Billion in 2024.
- The South Korea Lung Cancer Diagnostics Market is likely to grow at a CAGR of 23.65% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Non-Small Cell Lung Cancer in Cancer Segment accounted for the largest share of the market with a revenue of 59.37 USD Billion
- The fastest growing segment Hospital in End User Segment grew Fastest with a CAGR of 26.47% during the forecast period from 2024 to 2032.
South Korea Lung Cancer Diagnostics Market Scope
South Korea Lung Cancer Diagnostics Market Segmentation & Scope
Test
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
Product
- Consumables & Accessories
- Instruments
Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
Distribution Channel
- Retail Sales
- Direct Tender
South Korea Lung Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 77.53 USD Billion |
| Market Value in 2032 | 265.97 USD Billion |
| CAGR (2025-2032) | 23.65% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Test,Product,Cancer,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): South Korea, leading in terms of revenue 77.53 USD Billion in 2024
- Key Country: South Korea, leading in terms of revenue with value of 77.53 USD Billion in 2024.
Segments and Scope
-
South Korea Lung Cancer Diagnostics Market to 2032, By Test
- Imaging Test is the largest segment in South Korea Lung Cancer Diagnostics Market to 2032 with a revenue of 37.65 USD Billion in the year 2024.
- Imaging Test is the Fastest growing segment in South Korea Lung Cancer Diagnostics Market to 2032 with a Growth rate of 24.90 % in forecast period 2025-2032.
-
South Korea Lung Cancer Diagnostics Market to 2032, By Product
- Instruments is the largest segment in South Korea Lung Cancer Diagnostics Market to 2032 with a revenue of 48.99 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in South Korea Lung Cancer Diagnostics Market to 2032 with a Growth rate of 24.66 % in forecast period 2025-2032.
-
South Korea Lung Cancer Diagnostics Market to 2032, By Cancer
- Non-Small Cell Lung Cancer is the largest segment in South Korea Lung Cancer Diagnostics Market to 2032 with a revenue of 59.37 USD Billion in the year 2024.
- Non-Small Cell Lung Cancer is the Fastest growing segment in South Korea Lung Cancer Diagnostics Market to 2032 with a Growth rate of 23.92 % in forecast period 2025-2032.
-
South Korea Lung Cancer Diagnostics Market to 2032, By End User
- Hospital is the largest segment in South Korea Lung Cancer Diagnostics Market to 2032 with a revenue of 19.79 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in South Korea Lung Cancer Diagnostics Market to 2032 with a Growth rate of 26.47 % in forecast period 2025-2032.
-
South Korea Lung Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in South Korea Lung Cancer Diagnostics Market to 2032 with a revenue of 42.83 USD Billion in the year 2024.
- Direct Tender is the Fastest growing segment in South Korea Lung Cancer Diagnostics Market to 2032 with a Growth rate of 25.05 % in forecast period 2025-2032.
South Korea Lung Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Quest Diagnostics Incorporated | |||
| Bio-Rad Laboratories, Inc. | |||
| Abbott | |||
| Guardant Health | |||
South Korea Lung Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Billion
South Korea Lung Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The South Korea Lung Cancer Diagnostics Market is segmented based on Segmentation Test,Product,Cancer,End User,Distribution Channel.
South Korea Lung Cancer Diagnostics Market was valued at USD 77.53(Revenue in USD Billion) in 2021.
South Korea Lung Cancer Diagnostics Market is projected to grow at a CAGR of 23.65% during the forecast period of 2024 to 2032.
The Non-Small Cell Lung Cancer segment is expected to dominate the South Korea Lung Cancer Diagnostics Market, holding a largest market share of 59.37 USD Billion in 2024
South Korea Lung Cancer Diagnostics Market Scope
South Korea Lung Cancer Diagnostics Market Segmentation & Scope
Test
- Others
- Blood Test
- Biopsy
- Biomarkers Test
- Imaging Test
Product
- Consumables & Accessories
- Instruments
Cancer
- Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospital
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The South Korea Lung Cancer Diagnostics Market is segmented based on Segmentation Test,Product,Cancer,End User,Distribution Channel.
South Korea Lung Cancer Diagnostics Market was valued at USD 77.53(Revenue in USD Billion) in 2021.
South Korea Lung Cancer Diagnostics Market is projected to grow at a CAGR of 23.65% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Lung Cancer Diagnostics Market for final year is USD 265.97 (USD Billion).
South Korea Lung Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The South Korea Lung Cancer Diagnostics Market is segmented based on Segmentation Test,Product,Cancer,End User,Distribution Channel.
South Korea Lung Cancer Diagnostics Market was valued at USD 77.53(Revenue in USD Billion) in 2021.
South Korea Lung Cancer Diagnostics Market is projected to grow at a CAGR of 23.65% during the forecast period of 2024 to 2032.
The estimated market value of the South Korea Lung Cancer Diagnostics Market for final year is USD 265.97 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.